$763.91
+18.79 (+2.52%)
At Close: Jun 23, 2026
McKesson is a Growing Giant
01:02pm, Tuesday, 11'th Jun 2024
McKesson Corporation (MCK) is poised to grow due to an aging population and expanding Type 2 diabetes treatments.
Here's Why You Should Hold McKesson (MCK) in Your Portfolio Now
07:41am, Tuesday, 11'th Jun 2024
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
10:56am, Tuesday, 04'th Jun 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
McKesson's Board of Directors Elects Deborah Dunsire as New Director
08:00am, Monday, 03'rd Jun 2024
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that the McKesson board of directors has elected Dr. Deborah Dunsire as a director and member of the Compensation and T
Bulletproof Your Retirement: 3 Stocks That Will Stand the Test of Time
04:00pm, Sunday, 02'nd Jun 2024
In retirement, stability and downside protection are the main investment objectives. You need retirement-proof stocks that guarantee stable growth with minimal volatility to succeed.
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
10:00am, Friday, 31'st May 2024
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
11:21am, Tuesday, 21'st May 2024
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
Exchange Solutions Unveils Industry-First Generative AI Feature Enablement for a Loyalty Platform
02:00am, Monday, 20'th May 2024
BOSTON & TORONTO--(BUSINESS WIRE)--Exchange Solutions, a leading provider of personalized loyalty solutions, proudly announces the launch of groundbreaking Generative AI features integrated into its l
Here's Why McKesson (MCK) is a Strong Momentum Stock
10:56am, Friday, 17'th May 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
McKesson (MCK) Q4 Earnings Miss Estimates, Revenues Up Y/Y
01:46pm, Wednesday, 08'th May 2024
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
McKesson Corporation (MCK) Q4 2024 Earnings Call Transcript
08:01pm, Tuesday, 07'th May 2024
McKesson Corporation (NYSE:MCK ) Q4 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Rachel Rodriguez - VP of Investor Relations Brian Tyler - Chief Executive Officer Britt Vi
McKesson (MCK) Reports Q4 Earnings: What Key Metrics Have to Say
07:01pm, Tuesday, 07'th May 2024
The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimate
McKesson misses quarterly estimates as US pharmaceuticals segment weighs
06:59pm, Tuesday, 07'th May 2024
McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company's branded and specialty drugs that dragged sales in its U.S. pharmaceutical s
McKesson (MCK) Q4 Earnings and Revenues Lag Estimates
06:20pm, Tuesday, 07'th May 2024
McKesson (MCK) came out with quarterly earnings of $6.18 per share, missing the Zacks Consensus Estimate of $6.34 per share. This compares to earnings of $7.19 per share a year ago.
McKesson Corporation Reports Fiscal 2024 Fourth Quarter and Full Year Results
04:10pm, Tuesday, 07'th May 2024
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2024 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at inve
Sign In
Buy MCK